期刊文献+

盐酸氨溴索联合常规化疗治疗肺结核的疗效及护理措施 被引量:4

Efficacy of Ambroxol Hydrochloride Combined with Conventional Chemotherapy in Treatment of Pulmonary Tuberculosis and Nursing Intervention
下载PDF
导出
摘要 目的:探讨盐酸氨溴索联合常规化疗治疗肺结核的临床疗效及护理措施。方法:选取2016年1月至2017年6月武汉大学人民医院潜江医院收治的肺结核患者98例,根据抽选顺序进行单双号分组,单号为观察组,双号为对照组,每组49例。对照组患者给予常规化疗,观察组患者在对照组的基础上加用盐酸氨溴索治疗,两组患者均给予针对性的护理。观察两组患者的临床疗效、咳嗽和喘息消失时间、实验室检查情况及不良反应发生情况。结果:观察组患者的总有效率为97.96%(48/49),明显高于对照组的79.59%(39/49),差异有统计学意义(P<0.05)。观察组患者平均咳嗽、喘息消失时间分别为(4.33±1.91)、(6.25±1.47)d,明显短于对照组的(6.78±1.84)、(8.49±1.52)d,差异均有统计学意义(P<0.05)。两组患者实验室检查结果的差异无统计学意义(P>0.05)。观察组、对照组患者不良反应发生率分别为4.08%(2/49)、2.04%(1/49),差异无统计学意义(P>0.05)。结论:盐酸氨溴索联合常规化疗治疗肺结核的疗效显著,可加快临床症状消失,且不良反应少。 OBJECTIVE: To probe into the clinical efficacy of ambroxol hydrochloride combined with conventional chemotherapy intervention in treatment of pulmonary tuberculosis. METHODS: 98 patients with pulmonary tuberculosis admitted into Qianjiang Hospital of People's Hospital Affiliated to Wuhan University from Jan. 2016 to Jun. 2017 were extracted to be divided into observation group and control group via the selection order,with 49 cases in each. The control group was given conventional treatment, while the observation group additionally received ambroxol hydrochloride based on the control group,and two groups were given targeted care. The clinical efficacy,disappearance time of cough and wheezing,laboratory inspection and incidence of adverse drug reactions of two groups were observed. RESULTS: The total effective rate of observation group was 97. 96%( 48/49),significantly higher than that of control group( 79. 59%,39/49),with statistically significant difference( P〈0. 05). The average disappearance time of cough and wheezing of observation group were respectively( 4. 33 ± 1. 91) and( 6. 25 ± 1. 47) d,significantly shorter than that of control group [( 6. 78 ± 1. 84) and( 8. 49 ± 1. 52) d],with statistically significant difference( P〈0. 05). There was no significant difference in laboratory test results between the two groups( P〈0. 05). The incidence of adverse drug reactions of observation group and control group were respectively 4. 08%( 2/49) and 2. 04%( 1/49),the difference was not statistically significant( P〈0. 05). CONCLUSIONS: The efficacy of ambroxol hydrochloride combined with conventional chemotherapy in treatment of pulmonary tuberculosis is significant,which can accelerate the disappearance of clinical symptoms with fewer adverse drug reactions.
作者 吕桂芝 彭浩 LYU Guizhi;PENG Hao(Dept.of Infectious Disease,Qianjiang Hospital of People's Hospital Affiliated to Wuhan University,Hubei Qianjiang 433100,China)
出处 《中国医院用药评价与分析》 2018年第8期1058-1059,1062,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 肺结核 盐酸氨溴索 临床疗效 护理 Pulmonary tuberculosis Ambroxol hydrochloride Clinical efficacy Nursing
  • 相关文献

参考文献13

二级参考文献119

  • 1蔡冬格,李秀苾,杨春元.中药结核丸治疗老年初治涂阳肺结核患者的临床观察[J].医学信息(医学与计算机应用),2014,0(23):92-93. 被引量:1
  • 2蒋锦琴,黄卫平,张小贤,周海鸥,严杰.中药结核丸对结核分枝杆菌体内外抗菌效果的观察[J].江西医学检验,2005,23(6):521-522. 被引量:18
  • 3唐神结,肖和平.复治涂阳肺结核化疗方案刍议[J].中国防痨杂志,2006,28(2):69-70. 被引量:25
  • 4中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 5World Health Organization. Muhidrug and extensively drug- resistant TB (M./XDR-TB) : 2010 global report on surveillance and respons [ M ]. Geneva: World Health Organization,2010 : 1-3.
  • 6Seth S, Mewara A, Dhatwalia SK, et al. Prevalence of mnhidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India [ J ]. BMC Infect Dis, 2013,13 : 137.
  • 7Loddenkemper R, Hauer B. Drug-resistant tuberculosis a worldwide epidemic poses a new challenge [ J ]. Dtsch Arztebl Int, 2010, 107 : 10-19.
  • 8Blower SM, Chou T. Modeling the emergence of the hot zones: tuberculosis and the amplification dynamics of drug resistance [ J ]. Nat Med,2004,10: 1111-1116.
  • 9World Health Organization. Treatment of tuberculosis: guidelines for national programmes [ M ]. Geneva: World Health Organization, 2009:5-7.
  • 10World Health Organization. Compendium of indicators for monitoring and evaluating national tuberculosis programs [ M ]. Geneva: World Health Organization ,2004 : 15-17.

共引文献231

同被引文献45

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部